Global Non-prescription Drugs Market Growth 2024-2031

Report ID: 1358727 | Published Date: Jan 2025 | No. of Page: 127 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Non-prescription Drugs Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Non-prescription Drugs by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Non-prescription Drugs by Country/Region, 2017, 2022 & 2028
    2.2 Non-prescription Drugs Segment by Type
        2.2.1 Brand Drugs
        2.2.2 Generic Drug
    2.3 Non-prescription Drugs Sales by Type
        2.3.1 Global Non-prescription Drugs Sales Market Share by Type (2017-2022)
        2.3.2 Global Non-prescription Drugs Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Non-prescription Drugs Sale Price by Type (2017-2022)
    2.4 Non-prescription Drugs Segment by Application
        2.4.1 Hospital
        2.4.2 Clinic
        2.4.3 Other
    2.5 Non-prescription Drugs Sales by Application
        2.5.1 Global Non-prescription Drugs Sale Market Share by Application (2017-2022)
        2.5.2 Global Non-prescription Drugs Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Non-prescription Drugs Sale Price by Application (2017-2022)
3 Global Non-prescription Drugs by Company
    3.1 Global Non-prescription Drugs Breakdown Data by Company
        3.1.1 Global Non-prescription Drugs Annual Sales by Company (2020-2022)
        3.1.2 Global Non-prescription Drugs Sales Market Share by Company (2020-2022)
    3.2 Global Non-prescription Drugs Annual Revenue by Company (2020-2022)
        3.2.1 Global Non-prescription Drugs Revenue by Company (2020-2022)
        3.2.2 Global Non-prescription Drugs Revenue Market Share by Company (2020-2022)
    3.3 Global Non-prescription Drugs Sale Price by Company
    3.4 Key Manufacturers Non-prescription Drugs Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Non-prescription Drugs Product Location Distribution
        3.4.2 Players Non-prescription Drugs Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Non-prescription Drugs by Geographic Region
    4.1 World Historic Non-prescription Drugs Market Size by Geographic Region (2017-2022)
        4.1.1 Global Non-prescription Drugs Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Non-prescription Drugs Annual Revenue by Geographic Region
    4.2 World Historic Non-prescription Drugs Market Size by Country/Region (2017-2022)
        4.2.1 Global Non-prescription Drugs Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Non-prescription Drugs Annual Revenue by Country/Region
    4.3 Americas Non-prescription Drugs Sales Growth
    4.4 APAC Non-prescription Drugs Sales Growth
    4.5 Europe Non-prescription Drugs Sales Growth
    4.6 Middle East & Africa Non-prescription Drugs Sales Growth
5 Americas
    5.1 Americas Non-prescription Drugs Sales by Country
        5.1.1 Americas Non-prescription Drugs Sales by Country (2017-2022)
        5.1.2 Americas Non-prescription Drugs Revenue by Country (2017-2022)
    5.2 Americas Non-prescription Drugs Sales by Type
    5.3 Americas Non-prescription Drugs Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Non-prescription Drugs Sales by Region
        6.1.1 APAC Non-prescription Drugs Sales by Region (2017-2022)
        6.1.2 APAC Non-prescription Drugs Revenue by Region (2017-2022)
    6.2 APAC Non-prescription Drugs Sales by Type
    6.3 APAC Non-prescription Drugs Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Non-prescription Drugs by Country
        7.1.1 Europe Non-prescription Drugs Sales by Country (2017-2022)
        7.1.2 Europe Non-prescription Drugs Revenue by Country (2017-2022)
    7.2 Europe Non-prescription Drugs Sales by Type
    7.3 Europe Non-prescription Drugs Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Non-prescription Drugs by Country
        8.1.1 Middle East & Africa Non-prescription Drugs Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Non-prescription Drugs Revenue by Country (2017-2022)
    8.2 Middle East & Africa Non-prescription Drugs Sales by Type
    8.3 Middle East & Africa Non-prescription Drugs Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Non-prescription Drugs
    10.3 Manufacturing Process Analysis of Non-prescription Drugs
    10.4 Industry Chain Structure of Non-prescription Drugs
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Non-prescription Drugs Distributors
    11.3 Non-prescription Drugs Customer
12 World Forecast Review for Non-prescription Drugs by Geographic Region
    12.1 Global Non-prescription Drugs Market Size Forecast by Region
        12.1.1 Global Non-prescription Drugs Forecast by Region (2023-2028)
        12.1.2 Global Non-prescription Drugs Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Non-prescription Drugs Forecast by Type
    12.7 Global Non-prescription Drugs Forecast by Application
13 Key Players Analysis
    13.1 Pfizer
        13.1.1 Pfizer Company Information
        13.1.2 Pfizer Non-prescription Drugs Product Offered
        13.1.3 Pfizer Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Pfizer Main Business Overview
        13.1.5 Pfizer Latest Developments
    13.2 Roche
        13.2.1 Roche Company Information
        13.2.2 Roche Non-prescription Drugs Product Offered
        13.2.3 Roche Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Roche Main Business Overview
        13.2.5 Roche Latest Developments
    13.3 Sanofi
        13.3.1 Sanofi Company Information
        13.3.2 Sanofi Non-prescription Drugs Product Offered
        13.3.3 Sanofi Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Sanofi Main Business Overview
        13.3.5 Sanofi Latest Developments
    13.4 Johnson & Johnson
        13.4.1 Johnson & Johnson Company Information
        13.4.2 Johnson & Johnson Non-prescription Drugs Product Offered
        13.4.3 Johnson & Johnson Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Johnson & Johnson Main Business Overview
        13.4.5 Johnson & Johnson Latest Developments
    13.5 Merck & Co. (MSD)
        13.5.1 Merck & Co. (MSD) Company Information
        13.5.2 Merck & Co. (MSD) Non-prescription Drugs Product Offered
        13.5.3 Merck & Co. (MSD) Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Merck & Co. (MSD) Main Business Overview
        13.5.5 Merck & Co. (MSD) Latest Developments
    13.6 Novartis
        13.6.1 Novartis Company Information
        13.6.2 Novartis Non-prescription Drugs Product Offered
        13.6.3 Novartis Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Novartis Main Business Overview
        13.6.5 Novartis Latest Developments
    13.7 AbbVie
        13.7.1 AbbVie Company Information
        13.7.2 AbbVie Non-prescription Drugs Product Offered
        13.7.3 AbbVie Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 AbbVie Main Business Overview
        13.7.5 AbbVie Latest Developments
    13.8 Gilead Sciences
        13.8.1 Gilead Sciences Company Information
        13.8.2 Gilead Sciences Non-prescription Drugs Product Offered
        13.8.3 Gilead Sciences Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Gilead Sciences Main Business Overview
        13.8.5 Gilead Sciences Latest Developments
    13.9 GlaxoSmithKline (GSK)
        13.9.1 GlaxoSmithKline (GSK) Company Information
        13.9.2 GlaxoSmithKline (GSK) Non-prescription Drugs Product Offered
        13.9.3 GlaxoSmithKline (GSK) Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 GlaxoSmithKline (GSK) Main Business Overview
        13.9.5 GlaxoSmithKline (GSK) Latest Developments
    13.10 Amgen
        13.10.1 Amgen Company Information
        13.10.2 Amgen Non-prescription Drugs Product Offered
        13.10.3 Amgen Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Amgen Main Business Overview
        13.10.5 Amgen Latest Developments
    13.11 AstraZeneca
        13.11.1 AstraZeneca Company Information
        13.11.2 AstraZeneca Non-prescription Drugs Product Offered
        13.11.3 AstraZeneca Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 AstraZeneca Main Business Overview
        13.11.5 AstraZeneca Latest Developments
    13.12 Bristol-Myers Squibb
        13.12.1 Bristol-Myers Squibb Company Information
        13.12.2 Bristol-Myers Squibb Non-prescription Drugs Product Offered
        13.12.3 Bristol-Myers Squibb Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.12.4 Bristol-Myers Squibb Main Business Overview
        13.12.5 Bristol-Myers Squibb Latest Developments
    13.13 Eli Lilly
        13.13.1 Eli Lilly Company Information
        13.13.2 Eli Lilly Non-prescription Drugs Product Offered
        13.13.3 Eli Lilly Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.13.4 Eli Lilly Main Business Overview
        13.13.5 Eli Lilly Latest Developments
    13.14 Teva
        13.14.1 Teva Company Information
        13.14.2 Teva Non-prescription Drugs Product Offered
        13.14.3 Teva Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.14.4 Teva Main Business Overview
        13.14.5 Teva Latest Developments
    13.15 Bayer
        13.15.1 Bayer Company Information
        13.15.2 Bayer Non-prescription Drugs Product Offered
        13.15.3 Bayer Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.15.4 Bayer Main Business Overview
        13.15.5 Bayer Latest Developments
    13.16 Novo Nordisk
        13.16.1 Novo Nordisk Company Information
        13.16.2 Novo Nordisk Non-prescription Drugs Product Offered
        13.16.3 Novo Nordisk Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.16.4 Novo Nordisk Main Business Overview
        13.16.5 Novo Nordisk Latest Developments
    13.17 Allergan
        13.17.1 Allergan Company Information
        13.17.2 Allergan Non-prescription Drugs Product Offered
        13.17.3 Allergan Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.17.4 Allergan Main Business Overview
        13.17.5 Allergan Latest Developments
    13.18 Takeda
        13.18.1 Takeda Company Information
        13.18.2 Takeda Non-prescription Drugs Product Offered
        13.18.3 Takeda Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.18.4 Takeda Main Business Overview
        13.18.5 Takeda Latest Developments
    13.19 Boehringer Ingelheim
        13.19.1 Boehringer Ingelheim Company Information
        13.19.2 Boehringer Ingelheim Non-prescription Drugs Product Offered
        13.19.3 Boehringer Ingelheim Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.19.4 Boehringer Ingelheim Main Business Overview
        13.19.5 Boehringer Ingelheim Latest Developments
    13.20 Takeda
        13.20.1 Takeda Company Information
        13.20.2 Takeda Non-prescription Drugs Product Offered
        13.20.3 Takeda Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.20.4 Takeda Main Business Overview
        13.20.5 Takeda Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Non-prescription Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Non-prescription Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Brand Drugs
    Table 4. Major Players of Generic Drug
    Table 5. Global Non-prescription Drugs Sales by Type (2017-2022) & (K Units)
    Table 6. Global Non-prescription Drugs Sales Market Share by Type (2017-2022)
    Table 7. Global Non-prescription Drugs Revenue by Type (2017-2022) & ($ million)
    Table 8. Global Non-prescription Drugs Revenue Market Share by Type (2017-2022)
    Table 9. Global Non-prescription Drugs Sale Price by Type (2017-2022) & (USD/Unit)
    Table 10. Global Non-prescription Drugs Sales by Application (2017-2022) & (K Units)
    Table 11. Global Non-prescription Drugs Sales Market Share by Application (2017-2022)
    Table 12. Global Non-prescription Drugs Revenue by Application (2017-2022)
    Table 13. Global Non-prescription Drugs Revenue Market Share by Application (2017-2022)
    Table 14. Global Non-prescription Drugs Sale Price by Application (2017-2022) & (USD/Unit)
    Table 15. Global Non-prescription Drugs Sales by Company (2020-2022) & (K Units)
    Table 16. Global Non-prescription Drugs Sales Market Share by Company (2020-2022)
    Table 17. Global Non-prescription Drugs Revenue by Company (2020-2022) ($ Millions)
    Table 18. Global Non-prescription Drugs Revenue Market Share by Company (2020-2022)
    Table 19. Global Non-prescription Drugs Sale Price by Company (2020-2022) & (USD/Unit)
    Table 20. Key Manufacturers Non-prescription Drugs Producing Area Distribution and Sales Area
    Table 21. Players Non-prescription Drugs Products Offered
    Table 22. Non-prescription Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global Non-prescription Drugs Sales by Geographic Region (2017-2022) & (K Units)
    Table 26. Global Non-prescription Drugs Sales Market Share Geographic Region (2017-2022)
    Table 27. Global Non-prescription Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 28. Global Non-prescription Drugs Revenue Market Share by Geographic Region (2017-2022)
    Table 29. Global Non-prescription Drugs Sales by Country/Region (2017-2022) & (K Units)
    Table 30. Global Non-prescription Drugs Sales Market Share by Country/Region (2017-2022)
    Table 31. Global Non-prescription Drugs Revenue by Country/Region (2017-2022) & ($ millions)
    Table 32. Global Non-prescription Drugs Revenue Market Share by Country/Region (2017-2022)
    Table 33. Americas Non-prescription Drugs Sales by Country (2017-2022) & (K Units)
    Table 34. Americas Non-prescription Drugs Sales Market Share by Country (2017-2022)
    Table 35. Americas Non-prescription Drugs Revenue by Country (2017-2022) & ($ Millions)
    Table 36. Americas Non-prescription Drugs Revenue Market Share by Country (2017-2022)
    Table 37. Americas Non-prescription Drugs Sales by Type (2017-2022) & (K Units)
    Table 38. Americas Non-prescription Drugs Sales Market Share by Type (2017-2022)
    Table 39. Americas Non-prescription Drugs Sales by Application (2017-2022) & (K Units)
    Table 40. Americas Non-prescription Drugs Sales Market Share by Application (2017-2022)
    Table 41. APAC Non-prescription Drugs Sales by Region (2017-2022) & (K Units)
    Table 42. APAC Non-prescription Drugs Sales Market Share by Region (2017-2022)
    Table 43. APAC Non-prescription Drugs Revenue by Region (2017-2022) & ($ Millions)
    Table 44. APAC Non-prescription Drugs Revenue Market Share by Region (2017-2022)
    Table 45. APAC Non-prescription Drugs Sales by Type (2017-2022) & (K Units)
    Table 46. APAC Non-prescription Drugs Sales Market Share by Type (2017-2022)
    Table 47. APAC Non-prescription Drugs Sales by Application (2017-2022) & (K Units)
    Table 48. APAC Non-prescription Drugs Sales Market Share by Application (2017-2022)
    Table 49. Europe Non-prescription Drugs Sales by Country (2017-2022) & (K Units)
    Table 50. Europe Non-prescription Drugs Sales Market Share by Country (2017-2022)
    Table 51. Europe Non-prescription Drugs Revenue by Country (2017-2022) & ($ Millions)
    Table 52. Europe Non-prescription Drugs Revenue Market Share by Country (2017-2022)
    Table 53. Europe Non-prescription Drugs Sales by Type (2017-2022) & (K Units)
    Table 54. Europe Non-prescription Drugs Sales Market Share by Type (2017-2022)
    Table 55. Europe Non-prescription Drugs Sales by Application (2017-2022) & (K Units)
    Table 56. Europe Non-prescription Drugs Sales Market Share by Application (2017-2022)
    Table 57. Middle East & Africa Non-prescription Drugs Sales by Country (2017-2022) & (K Units)
    Table 58. Middle East & Africa Non-prescription Drugs Sales Market Share by Country (2017-2022)
    Table 59. Middle East & Africa Non-prescription Drugs Revenue by Country (2017-2022) & ($ Millions)
    Table 60. Middle East & Africa Non-prescription Drugs Revenue Market Share by Country (2017-2022)
    Table 61. Middle East & Africa Non-prescription Drugs Sales by Type (2017-2022) & (K Units)
    Table 62. Middle East & Africa Non-prescription Drugs Sales Market Share by Type (2017-2022)
    Table 63. Middle East & Africa Non-prescription Drugs Sales by Application (2017-2022) & (K Units)
    Table 64. Middle East & Africa Non-prescription Drugs Sales Market Share by Application (2017-2022)
    Table 65. Key Market Drivers & Growth Opportunities of Non-prescription Drugs
    Table 66. Key Market Challenges & Risks of Non-prescription Drugs
    Table 67. Key Industry Trends of Non-prescription Drugs
    Table 68. Non-prescription Drugs Raw Material
    Table 69. Key Suppliers of Raw Materials
    Table 70. Non-prescription Drugs Distributors List
    Table 71. Non-prescription Drugs Customer List
    Table 72. Global Non-prescription Drugs Sales Forecast by Region (2023-2028) & (K Units)
    Table 73. Global Non-prescription Drugs Sales Market Forecast by Region
    Table 74. Global Non-prescription Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 75. Global Non-prescription Drugs Revenue Market Share Forecast by Region (2023-2028)
    Table 76. Americas Non-prescription Drugs Sales Forecast by Country (2023-2028) & (K Units)
    Table 77. Americas Non-prescription Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 78. APAC Non-prescription Drugs Sales Forecast by Region (2023-2028) & (K Units)
    Table 79. APAC Non-prescription Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 80. Europe Non-prescription Drugs Sales Forecast by Country (2023-2028) & (K Units)
    Table 81. Europe Non-prescription Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 82. Middle East & Africa Non-prescription Drugs Sales Forecast by Country (2023-2028) & (K Units)
    Table 83. Middle East & Africa Non-prescription Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Global Non-prescription Drugs Sales Forecast by Type (2023-2028) & (K Units)
    Table 85. Global Non-prescription Drugs Sales Market Share Forecast by Type (2023-2028)
    Table 86. Global Non-prescription Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 87. Global Non-prescription Drugs Revenue Market Share Forecast by Type (2023-2028)
    Table 88. Global Non-prescription Drugs Sales Forecast by Application (2023-2028) & (K Units)
    Table 89. Global Non-prescription Drugs Sales Market Share Forecast by Application (2023-2028)
    Table 90. Global Non-prescription Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 91. Global Non-prescription Drugs Revenue Market Share Forecast by Application (2023-2028)
    Table 92. Pfizer Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 93. Pfizer Non-prescription Drugs Product Offered
    Table 94. Pfizer Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 95. Pfizer Main Business
    Table 96. Pfizer Latest Developments
    Table 97. Roche Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 98. Roche Non-prescription Drugs Product Offered
    Table 99. Roche Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 100. Roche Main Business
    Table 101. Roche Latest Developments
    Table 102. Sanofi Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 103. Sanofi Non-prescription Drugs Product Offered
    Table 104. Sanofi Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 105. Sanofi Main Business
    Table 106. Sanofi Latest Developments
    Table 107. Johnson & Johnson Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 108. Johnson & Johnson Non-prescription Drugs Product Offered
    Table 109. Johnson & Johnson Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 110. Johnson & Johnson Main Business
    Table 111. Johnson & Johnson Latest Developments
    Table 112. Merck & Co. (MSD) Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 113. Merck & Co. (MSD) Non-prescription Drugs Product Offered
    Table 114. Merck & Co. (MSD) Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 115. Merck & Co. (MSD) Main Business
    Table 116. Merck & Co. (MSD) Latest Developments
    Table 117. Novartis Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 118. Novartis Non-prescription Drugs Product Offered
    Table 119. Novartis Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 120. Novartis Main Business
    Table 121. Novartis Latest Developments
    Table 122. AbbVie Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 123. AbbVie Non-prescription Drugs Product Offered
    Table 124. AbbVie Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 125. AbbVie Main Business
    Table 126. AbbVie Latest Developments
    Table 127. Gilead Sciences Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 128. Gilead Sciences Non-prescription Drugs Product Offered
    Table 129. Gilead Sciences Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 130. Gilead Sciences Main Business
    Table 131. Gilead Sciences Latest Developments
    Table 132. GlaxoSmithKline (GSK) Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 133. GlaxoSmithKline (GSK) Non-prescription Drugs Product Offered
    Table 134. GlaxoSmithKline (GSK) Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 135. GlaxoSmithKline (GSK) Main Business
    Table 136. GlaxoSmithKline (GSK) Latest Developments
    Table 137. Amgen Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 138. Amgen Non-prescription Drugs Product Offered
    Table 139. Amgen Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 140. Amgen Main Business
    Table 141. Amgen Latest Developments
    Table 142. AstraZeneca Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 143. AstraZeneca Non-prescription Drugs Product Offered
    Table 144. AstraZeneca Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 145. AstraZeneca Main Business
    Table 146. AstraZeneca Latest Developments
    Table 147. Bristol-Myers Squibb Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 148. Bristol-Myers Squibb Non-prescription Drugs Product Offered
    Table 149. Bristol-Myers Squibb Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 150. Bristol-Myers Squibb Main Business
    Table 151. Bristol-Myers Squibb Latest Developments
    Table 152. Eli Lilly Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 153. Eli Lilly Non-prescription Drugs Product Offered
    Table 154. Eli Lilly Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 155. Eli Lilly Main Business
    Table 156. Eli Lilly Latest Developments
    Table 157. Teva Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 158. Teva Non-prescription Drugs Product Offered
    Table 159. Teva Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 160. Teva Main Business
    Table 161. Teva Latest Developments
    Table 162. Bayer Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 163. Bayer Non-prescription Drugs Product Offered
    Table 164. Bayer Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 165. Bayer Main Business
    Table 166. Bayer Latest Developments
    Table 167. Novo Nordisk Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 168. Novo Nordisk Non-prescription Drugs Product Offered
    Table 169. Novo Nordisk Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 170. Novo Nordisk Main Business
    Table 171. Novo Nordisk Latest Developments
    Table 172. Allergan Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 173. Allergan Non-prescription Drugs Product Offered
    Table 174. Allergan Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 175. Allergan Main Business
    Table 176. Allergan Latest Developments
    Table 177. Takeda Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 178. Takeda Non-prescription Drugs Product Offered
    Table 179. Takeda Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 180. Takeda Main Business
    Table 181. Takeda Latest Developments
    Table 182. Boehringer Ingelheim Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 183. Boehringer Ingelheim Non-prescription Drugs Product Offered
    Table 184. Boehringer Ingelheim Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 185. Boehringer Ingelheim Main Business
    Table 186. Boehringer Ingelheim Latest Developments
    Table 187. Takeda Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 188. Takeda Non-prescription Drugs Product Offered
    Table 189. Takeda Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 190. Takeda Main Business
    Table 191. Takeda Latest Developments
List of Figures
    Figure 1. Picture of Non-prescription Drugs
    Figure 2. Non-prescription Drugs Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Non-prescription Drugs Sales Growth Rate 2017-2028 (K Units)
    Figure 7. Global Non-prescription Drugs Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Non-prescription Drugs Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Brand Drugs
    Figure 10. Product Picture of Generic Drug
    Figure 11. Global Non-prescription Drugs Sales Market Share by Type in 2021
    Figure 12. Global Non-prescription Drugs Revenue Market Share by Type (2017-2022)
    Figure 13. Non-prescription Drugs Consumed in Hospital
    Figure 14. Global Non-prescription Drugs Market: Hospital (2017-2022) & (K Units)
    Figure 15. Non-prescription Drugs Consumed in Clinic
    Figure 16. Global Non-prescription Drugs Market: Clinic (2017-2022) & (K Units)
    Figure 17. Non-prescription Drugs Consumed in Other
    Figure 18. Global Non-prescription Drugs Market: Other (2017-2022) & (K Units)
    Figure 19. Global Non-prescription Drugs Sales Market Share by Application (2017-2022)
    Figure 20. Global Non-prescription Drugs Revenue Market Share by Application in 2021
    Figure 21. Non-prescription Drugs Revenue Market by Company in 2021 ($ Million)
    Figure 22. Global Non-prescription Drugs Revenue Market Share by Company in 2021
    Figure 23. Global Non-prescription Drugs Sales Market Share by Geographic Region (2017-2022)
    Figure 24. Global Non-prescription Drugs Revenue Market Share by Geographic Region in 2021
    Figure 25. Global Non-prescription Drugs Sales Market Share by Region (2017-2022)
    Figure 26. Global Non-prescription Drugs Revenue Market Share by Country/Region in 2021
    Figure 27. Americas Non-prescription Drugs Sales 2017-2022 (K Units)
    Figure 28. Americas Non-prescription Drugs Revenue 2017-2022 ($ Millions)
    Figure 29. APAC Non-prescription Drugs Sales 2017-2022 (K Units)
    Figure 30. APAC Non-prescription Drugs Revenue 2017-2022 ($ Millions)
    Figure 31. Europe Non-prescription Drugs Sales 2017-2022 (K Units)
    Figure 32. Europe Non-prescription Drugs Revenue 2017-2022 ($ Millions)
    Figure 33. Middle East & Africa Non-prescription Drugs Sales 2017-2022 (K Units)
    Figure 34. Middle East & Africa Non-prescription Drugs Revenue 2017-2022 ($ Millions)
    Figure 35. Americas Non-prescription Drugs Sales Market Share by Country in 2021
    Figure 36. Americas Non-prescription Drugs Revenue Market Share by Country in 2021
    Figure 37. United States Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 38. Canada Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 39. Mexico Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 40. Brazil Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 41. APAC Non-prescription Drugs Sales Market Share by Region in 2021
    Figure 42. APAC Non-prescription Drugs Revenue Market Share by Regions in 2021
    Figure 43. China Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Japan Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 45. South Korea Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Southeast Asia Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 47. India Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Australia Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 49. Europe Non-prescription Drugs Sales Market Share by Country in 2021
    Figure 50. Europe Non-prescription Drugs Revenue Market Share by Country in 2021
    Figure 51. Germany Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 52. France Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 53. UK Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Italy Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 55. Russia Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 56. Middle East & Africa Non-prescription Drugs Sales Market Share by Country in 2021
    Figure 57. Middle East & Africa Non-prescription Drugs Revenue Market Share by Country in 2021
    Figure 58. Egypt Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 59. South Africa Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 60. Israel Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Turkey Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 62. GCC Country Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 63. Manufacturing Cost Structure Analysis of Non-prescription Drugs in 2021
    Figure 64. Manufacturing Process Analysis of Non-prescription Drugs
    Figure 65. Industry Chain Structure of Non-prescription Drugs
    Figure 66. Channels of Distribution
    Figure 67. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Non-prescription Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Non-prescription Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Non-prescription Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports